Inflammatory Bowel Diseases & Disorders deals with colon and small intestine inflammatory conditions, mainly Ulcerative colitis and Crohn’s disease. Inflammatory Bowel disease may also result in colon cancer. Collagenous colitis and lymphocytic colitis are also considered under inflammatory bowel disease.
The Journal of Inflammatory Bowel Diseases & Disorders accepts articles in the form of research articles, review articles, short communications, letter to editors, commentaries, case reports, etc. This journal is a peer reviewed open access scholarly journal dedicated towards distribution of valuable information for the societal benefit.
Journal of Inflammatory Bowel Diseases & Disorders follows Editorial Manager System for quality in peer review process. Editorial Manager is an online manuscript submission, review and tracking systems used by most of the best open access journals.
Authors are requested to submit manuscripts at https://www.scholarscentral.org/submissions/inflammatory-bowel-diseases-disorders.html or send as an e-mail attachment to the Editorial Office at manuscripts@hilarispublisher.com
Hilaris SRL organizes 1000+ conferences every year across USA, Europe & Asia with support from more than 1000 scientific societies and publishes 700+ open access journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.
Rapid Publication Service
Hilaris Publishing is offering wide range of opportunities, options and services for the prospective authors to publish their scholarly contributions.
The journal caters to the demands of the fast publication without compromising on the editorial quality including manuscript peer-review. This flexibility is being provided to ensure earliest author credibility to their respective contributions and this will also ensure timely dissemination of research outcomes for efficient integration, effective translation and reduced redundancy.
Authors have the option to choose between the standard open access publication service which takes its own course of time for complete publication process or can opt for rapid publication service wherein the article is published at the earliest date (Includes multiple subject experts commissioning for securing earliest peer-review comments). The authors can avail this flexibility based on the personal preference, funding agency guidelines or Institutional or organizational requirements.
Regardless of the option, all manuscripts undergo thorough peer-review process, editorial assessment and production process.
Fast Editorial Execution and Review Process (FEE-Review Process)
Authors who are willing to publish their articles under this mode can make a pre-payment of $99 towards express peer-review and editorial decision. First editorial decision in 3 days and final decision with review comments in 5 days from the date of submission. Galley proof generation will be done in next 2 days from acceptance or maximum 5 days (For manuscripts notified for revision by external reviewer).
Manuscripts accepted for publication will be charged regular APC.
Authors retain the copyright of their publication and the final version of the article will be published in both HTML and PDF formats as well as XML formats for transmitting to indexing databases. The editorial team of the Journal will ensure adherence to scientific publication guidelines.
Articles published in Journal of Inflammatory Bowel Diseases & Disorders have been cited by esteemed scholars and scientists all around the world. Journal of Inflammatory Bowel Diseases & Disorders has got h-index 5 , which means every article in Journal of Inflammatory Bowel Diseases & Disorders has got 5 average citations.
Marco Imbalzano*
2021 Conference Announcement
Marco Imbalzano*
2021 Conference Announcement
Marco Imbalzano*
2021 Conference Announcement
Marco Imbalzano*
2021 Conference Announcement
